TXG
Companies
NASDAQ
10x Genomics Inc.
Health Care
$10.87
-$3.49 (-24.30%)
Price Chart
Overview
About TXG
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Market Cap
$2.6B
Volume
34.9M
Avg. Volume
34.9M
P/E Ratio
-5.852459
Dividend Yield
0.00%
Employees
1.5K
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Health Information Services
Website
Risk & Correlation Analysis
Market Correlation
1.65
High Correlation
Volatility
High (0.68)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TXG shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.6B
Volume34.9M
P/E Ratio-5.85
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 13, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025